Training the Medicine Makers the UK Can’t Afford to Lose

Why immersive training could be critical to closing the UK’s medicines manufacturing skills gap

1

The UK aims to be a leading life science nation by 2030, but faces significant skills gaps and declining clinical trial numbers.
2

Virtual reality (VR) is enhancing training for medicine makers by providing a cost-effective, scalable, and safe learning environment.
3

The UK has seen a 41% decline in industry clinical trials from 2017 to 2021, impacting its global pharmaceutical standing.
4

The RESILIENCE program has trained over 13,500 students through outreach and industry-relevant events since its inception.
5

VR training allows for repetitive practice without material waste, addressing the high costs and complexities of traditional lab training.

1